CMS COVID-19 Data Products

On January 31, 2020, the U.S. Department of Health and Human Services Secretary declared a public health emergency for the United States to aid the nation’s healthcare community in responding to an outbreak of respiratory disease caused by a coronavirus named “Coronavirus Disease 2019” (abbreviated “COVID-19”). On March 13, 2020, a national emergency concerning COVID-19 was declared. 

CMS is committed to data transparency to highlight the impacts of COVID-19 and advance public health policies. Please use the navigation bar to the left to access the following COVID-19 data products:

• Unwinding Reporting: Get data and information about how states are resuming Medicaid and CHIP renewal processes.
• Medicare COVID-19 Hospitalization Trend Report: Supplemental report that highlights trends in Medicare COVID-19 hospitalizations cut by month and various demographic characteristics.
• Medicare COVID-19 Vaccine Analysis: Presents COVID-19 vaccine administration and payment data. Includes important information assessing the completeness of Medicare claims data for measuring COVID-19 vaccine administration.
• Medicare COVID-19 Nursing Home Analysis: Reports information on the impact of COVID-19 on Medicare beneficiaries in nursing homes.
• Medicare COVID-19 Nursing Home Data: Information on COVID-19 reported by nursing homes to the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN).
• Medicare Current Beneficiary Survey (MCBS) COVID-19 PUFs: Supplemental public use files containing survey data collected from Medicare beneficiaries on their experiences with the COVID-19 pandemic.
• MCBS Summer 2020 COVID-19 Data Snapshot: Infographic that presents information on Medicare beneficiaries’ experiences with the COVID-19 pandemic that was collected from June 10, 2020 through July 15, 2020.
• MCBS Fall 2020 COVID-19 Data Snapshot: Infographic that presents information on Medicare beneficiaries’ experiences with the COVID-19 pandemic that was collected from October 5, 2020 through November 15, 2020.
• MCBS COVID-19 Winter 2021 Data Snapshot: Infographic that presents information on Medicare beneficiaries’ experiences with the COVID-19 pandemic that was collected from March 1, 2021 to April 25, 2021.
• Medicaid & CHIP COVID-19 Data Releases: Medicaid.gov webpage with listing of Medicaid and CHIP COVID-19 resources and public data releases.
• Access to Medication for Opioid Use Disorder (MOUD) Among Medicare Fee-for-Service Beneficiaries: Influence of CARES Act Implementation (2020) (PDF): This data highlight describes and compares sociodemographic, health condition characteristics, and health care utilization, including use of telehealth, among patients enrolled in Medicare Fee-for-Service who have opioid use disorder, examining the data before and after the onset of the COVID-19 pandemic and implementation of the CARES Act.
• Changes in Access to Medication Treatment during COVID-19 Telehealth Expansion and Disparities in Telehealth Use for Medicare Beneficiaries with Opioid Use Disorder (PDF):  This data highlight compares access to medication treatment for Medicare enrollees diagnosed with opioid use disorder before and after COVID-19 telehealth expansion was implemented. 
• CARES Act Telehealth Expansion: Trends in Post-Discharge Follow-Up and Association with 30-Day Readmissions for Hospital Readmissions Reduction Program Health Conditions (PDF): This data highlight expands on monthly trends in hospitalizations for Medicare fee-for-service Medicare enrollees for the Hospital Readmissions Reduction Program (HRRP), comparing trends before and in the six months after the CARES Act telehealth expansion.
• COVID-19 National Emergency: Early Trends in Hospitalizations for Hospital Readmissions Reduction Program Health Conditions and 30-Day Readmission Rates (PDF): This data highlight characterizes monthly trends in hospitalizations for Medicare fee-for-service Medicare enrollees for the Hospital Readmissions Reduction Program (HRRP). 

This is an ongoing situation and we will continue to make updates and provide additional resources. For more information, see CMS’s COVID-19 webpage.